tiprankstipranks
Trending News
More News >
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ

Jazz Pharmaceuticals (JAZZ) Revenue

Compare
1,873 Followers

Jazz Pharmaceuticals Revenue

Jazz Pharmaceuticals had a revenue of 1.20B in the quarter ending Dec 31, 2025, with 6.38%. This bring the company's revenue in the last twelve months to 4.27B, Decreased 2.64%. In the fiscal year ending Dec 31, 2025, Jazz Pharmaceuticals had annual revenue of 4.27B with 4.88% growth.
Revenue (ttm)
4.27B
Revenue Growth
4.14%
P/S Ratio
2.67
Revenue/Employee
$1,524,138
Employees
2,800
Market Cap
$11.42B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
4.27B198.64M+4.88%
Dec 31, 2024
4.07B234.75M+6.12%
Dec 31, 2023
3.83B174.83M+4.78%
Dec 31, 2022
3.66B565.14M+18.26%
Dec 31, 2021
3.09B730.67M+30.91%
Dec 31, 2020
2.36B201.81M+9.34%
Dec 31, 2019
2.16B270.84M+14.32%
Dec 31, 2018
1.89B272.23M+16.82%
Dec 31, 2017
1.62B